Información de Charles River Laboratories International Inc, dividendo de Charles River Laboratories International Inc, actividades de los accionistas y más

Más Datos de Charles River Laboratories International Inc Compañía

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Información de Charles River Laboratories International Inc



Símbolo de cotizaciónCRL

Nombre de la empresaCharles River Laboratories International Inc

Fecha de salida a bolsaJun 23, 2000

Director ejecutivoMr James C. Foster

Número de empleados18600

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 23

Dirección251 Ballardvale St

CiudadWILMINGTON

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal01887

Teléfono17812226000

Sitio Webhttps://www.criver.com/

Símbolo de cotizaciónCRL

Fecha de salida a bolsaJun 23, 2000

Director ejecutivoMr James C. Foster

Ejecutivos de Charles River Laboratories International Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

12.48K

-8.77%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

Dr. Nancy C. Andrews, M.D., Ph.D.

Independent Director

3.96K

+31.35%

Ms. Reshema Kemps-Polanco

Independent Director

2.59K

+155.42%

Dr. Craig B. Thompson, M.D.

Independent Director

2.41K

+64.49%

Mr. Abraham N. (Abe) Ceesay

Independent Director

946.00

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

12.48K

-8.77%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

Por negocioUSD

Nombre

Ganancia

Proporción

DSA

618.03M

59.88%

RMS

213.27M

20.66%

Manufacturing

200.84M

19.46%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

549.86M

53.27%

Europe

281.86M

27.31%

Canada

135.59M

13.14%

Asia Pacific (Region)

54.50M

5.28%

Other

10.33M

1.00%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

DSA

618.03M

59.88%

RMS

213.27M

20.66%

Manufacturing

200.84M

19.46%

Estadísticas de accionistas

Actualizado: mié., 8 de oct

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

11.79%

Wellington Management Company, LLP

7.66%

BlackRock Institutional Trust Company, N.A.

5.59%

Allspring Global Investments, LLC

4.43%

State Street Investment Management (US)

3.78%

Otro

66.77%

Accionistas

Proporción

The Vanguard Group, Inc.

11.79%

Wellington Management Company, LLP

7.66%

BlackRock Institutional Trust Company, N.A.

5.59%

Allspring Global Investments, LLC

4.43%

State Street Investment Management (US)

3.78%

Otro

66.77%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

43.53%

Investment Advisor/Hedge Fund

41.31%

Hedge Fund

9.40%

Research Firm

5.95%

Bank and Trust

2.19%

Pension Fund

1.50%

Individual Investor

1.05%

Sovereign Wealth Fund

1.04%

Private Equity

0.20%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

1382

51.79M

105.23%

-10.91M

2025Q2

1399

56.14M

114.06%

-4.38M

2025Q1

1435

55.38M

112.72%

-5.93M

2024Q4

1423

54.85M

107.26%

-4.35M

2024Q3

1392

53.78M

105.14%

-5.12M

2024Q2

1399

54.00M

104.84%

-4.00M

2024Q1

1393

53.76M

104.37%

-4.04M

2023Q4

1424

53.56M

104.42%

-4.24M

2023Q3

1446

53.56M

104.42%

-3.98M

2023Q2

1427

52.88M

103.32%

-3.95M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

5.80M

11.79%

-293.30K

-4.81%

Jun 30, 2025

Wellington Management Company, LLP

3.77M

7.66%

-517.21K

-12.07%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.75M

5.59%

-156.85K

-5.39%

Jun 30, 2025

Allspring Global Investments, LLC

2.29M

4.66%

+516.52K

+29.11%

Jun 30, 2025

State Street Investment Management (US)

1.86M

3.78%

-43.84K

-2.30%

Jun 30, 2025

Nomura Securities Co., Ltd.

1.57M

3.19%

+967.65K

+160.84%

Jun 30, 2025

Ariel Investments, LLC

1.42M

2.88%

+314.57K

+28.58%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.23M

2.5%

-31.43K

-2.49%

Jun 30, 2025

Harris Associates L.P.

1.16M

2.36%

+1.16M

--

Jun 30, 2025

Invesco Capital Management LLC

1.09M

2.22%

+110.27K

+11.23%

Jun 30, 2025

ETFs relacionados



Actualizado: lun., 6 de oct

Nombre

Proporción

First Trust NASDAQ Pharmaceuticals ETF

2.13%

Invesco S&P 500 Equal Weight Health Care ETF

1.78%

VanEck Biotech ETF

1.62%

Schwab Ariel Opportunities ETF

1.61%

ROBO Global Healthcare Technology & Innovation ETF

1.56%

Franklin Genomic Advancements ETF

1.37%

iShares Health Innovation Active ETF

1.29%

Principal Quality ETF

1.01%

WisdomTree US Value Fund

0.98%

Invesco S&P 500 High Beta ETF

0.93%

First Trust NASDAQ Pharmaceuticals ETF

Proporción2.13%

Invesco S&P 500 Equal Weight Health Care ETF

Proporción1.78%

VanEck Biotech ETF

Proporción1.62%

Schwab Ariel Opportunities ETF

Proporción1.61%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.56%

Franklin Genomic Advancements ETF

Proporción1.37%

iShares Health Innovation Active ETF

Proporción1.29%

Principal Quality ETF

Proporción1.01%

WisdomTree US Value Fund

Proporción0.98%

Invesco S&P 500 High Beta ETF

Proporción0.93%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos